Citadel Advisors - ONCOSEC MED INC ownership

ONCOSEC MED INC's ticker is ONCSXXXX and the CUSIP is 68234L207. A total of 37 filers reported holding ONCOSEC MED INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ONCOSEC MED INC
ValueSharesWeighting
Q4 2018$22,000
+46.7%
34,143
+216.8%
0.00%
Q2 2018$15,000
-44.4%
10,779
-61.2%
0.00%
Q3 2017$27,000
+50.0%
27,757
+83.6%
0.00%
Q2 2017$18,000
-47.1%
15,121
-43.7%
0.00%
Q1 2017$34,00026,8480.00%
Other shareholders
ONCOSEC MED INC shareholders Q4 2017
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 975,839$1,255,0000.07%
Acrospire Investment Management LLC 18,280$23,0000.02%
SANDERS MORRIS HARRIS LLC 50,000$64,0000.01%
FIRST FINANCIAL EQUITY CORPORATION 26,000$35,0000.01%
Virtu KCG Holdings LLC 66,253$85,0000.00%
WESPAC Advisors SoCal, LLC 200$256,0000.00%
BANK OF AMERICA CORP /DE/ 978$1,0000.00%
NORTHERN TRUST CORP 23,627$30,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 57,031$72,0000.00%
MILLENNIUM MANAGEMENT LLC 14,476$19,0000.00%
View complete list of ONCOSEC MED INC shareholders